ENDOPHTHALMITIS VITRECTOMY STUDY COORDINATING CENTER
眼内炎玻璃体切除术研究协调中心
基本信息
- 批准号:3559713
- 负责人:
- 金额:$ 27.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-07-01 至 1994-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Endophthalmitis Vitrectomy Study (EVS) is a prospective, randomized,
multicenter clinical trial designed to determine the role of pars plana
vitrectomy in the initial management of patients with bacterial
endophthalmitis. This is an application to serve as Coordinating Center
for this study, with primary responsibility for study organization, data
management and statistical analysis. The accompanying Study chair
application presents the study protocol and includes as appendices the
manual operation and data collection forms.
Investigators from the Epidemiology Data Center at the University of
Pittsburgh propose to continue to work with the Study Chair and other
clinical investigators to make final revisions to study protocol, manual of
operations and data collection forms. The Coordinating Center will be
responsible for preparing the randomized scheme, interim monitoring and
reporting to the Safety and Data Monitoring Committee. Data will be
received, processed and managed on the Data Center system of IBM
microcomputers and mainframe VAX. The trial will compare treatment
strategies for endophthalmitis and as such "intention to treat" will be
primary method of analysis. Analysis methods will be developed and tested
during data acquisition phases and final analysis and reports will be
generated during the last phase.
眼内炎玻璃体切除术研究(EVS)是一项前瞻性、随机、
多中心临床试验旨在确定睫状体平坦部的作用
玻璃体切除术在细菌性角膜炎初期治疗中的应用
眼内炎 这是作为协调中心的应用程序
对于本研究,主要负责研究组织、数据
管理和统计分析。 随行的研究椅
本申请提供了研究方案,并作为附录包括
手工操作和数据收集表格。
来自纽约大学流行病学数据中心的研究人员
匹兹堡提议继续与研究主席和其他
临床研究者对研究方案、手册
业务和数据收集表格。 协调中心将
负责制定随机方案、中期监测和
向安全性和数据监查委员会报告。 数据将
在IBM的数据中心系统上接收、处理和管理
微型计算机和大型VAX。 试验将比较治疗
眼内炎的治疗策略以及“意向性治疗”,
主要分析方法。 将制定和测试分析方法
在数据采集阶段,最终分析和报告将
在最后一个阶段产生的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheryl F Kelsey其他文献
Simpson's paradox and clinical trials: What you find is not necessarily what you prove
- DOI:
10.1016/s0196-0644(05)80066-6 - 发表时间:
1992-12-01 - 期刊:
- 影响因子:
- 作者:
Norman S Abramson;Sheryl F Kelsey;Peter Safar;Kim Sutton-Tyrrell - 通讯作者:
Kim Sutton-Tyrrell
1119-93 Any measurable coronary artery disease identified in women presenting with ischemic chest pain is associated with an adverse outcome: Findings from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Womens Ischemia Syndrome Evaluation (WISE) study angiographic core laboratory
- DOI:
10.1016/s0735-1097(04)91235-1 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Barry L Sharaf;Leslee Shaw;B.Della Johnson;Sheryl F Kelsey;Marian B Olson;Sunil Mankad;William J Rogers;Steven E Reis;Carl J Pepine;C.Noel Bairey Merz - 通讯作者:
C.Noel Bairey Merz
Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
- DOI:
10.1186/1532-429x-15-s1-p273 - 发表时间:
2013-01-30 - 期刊:
- 影响因子:
- 作者:
Mark Doyle;Gerald M Pohost;Leslee J Shaw;Diane A Vido;Sheryl F Kelsey;BD Johnson;William J Rogers;Geetha Rayarao;Barry L Sharaf;Carl J Pepine;Noel B Merz;Robert W Biederman - 通讯作者:
Robert W Biederman
Primer: practical approach to the selection of patients for and application of EECP
入门:选择接受 EECP 治疗的患者及应用 EECP 的实用方法
- DOI:
10.1038/ncpcardio0691 - 发表时间:
2006-11-01 - 期刊:
- 影响因子:44.200
- 作者:
Andrew D Michaels;Peter A McCullough;Ozlem Z Soran;William E Lawson;Gregory W Barsness;Timothy D Henry;Georgiann Linnemeier;Anthony Ochoa;Sheryl F Kelsey;Elizabeth D Kennard - 通讯作者:
Elizabeth D Kennard
1172-76 Healthcare costs for cardiovascular disease in women with and without obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-Sponsored Women's Ischemia Syndrome evaluation (WISE)
- DOI:
10.1016/s0735-1097(04)91781-0 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Leslee J Shaw;Barry L Sharaf;B.Delia Johnson;George Sopko;Carl J Pepine;Gerry Pohost;Steve Reis;William Rogers;Sheryl F Kelsey;C.Noel Bairey Merz; The WISE Study Group - 通讯作者:
The WISE Study Group
Sheryl F Kelsey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheryl F Kelsey', 18)}}的其他基金
Cardiovascular Events in Women's Ischemia Syndrome Evaluation
女性缺血综合征评估中的心血管事件
- 批准号:
7682197 - 财政年份:2008
- 资助金额:
$ 27.2万 - 项目类别:
Cardiovascular Events in Women's Ischemia Syndrome Evaluation
女性缺血综合征评估中的心血管事件
- 批准号:
7509288 - 财政年份:2008
- 资助金额:
$ 27.2万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 27.2万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 27.2万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 27.2万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 27.2万 - 项目类别:
Studentship